Status:
ACTIVE_NOT_RECRUITING
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
30-64 years
Phase:
NA
Brief Summary
This stage I clinical trial compares a genetic counseling patient preference (GCPP) intervention via EHR MyChart patient portal to conventional genetic counseling for women at elevated risk for breast...
Detailed Description
PRIMARY OBJECTIVE: I. Determine the efficacy of genetic counseling patient preference (GCPP) compared to conventional genetic counseling for adherence to National Comprehensive Cancer Network (NCCN) ...
Eligibility Criteria
Inclusion
- Being female.
- Ages 30-64.
- Being an Ohio State University (OSU) patient who uses MyChart.
- Undergoing routine screening mammography.
- Normal BI-RADS1.
- At elevated breast cancer risk by the Cancer Risk Assessment (CRA) tool.
- Able to read and speak English.
- Provide consent.
Exclusion
- Previous genetic counseling.
- Previous genetic testing for cancer risk or known mutation in a breast cancer gene: ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, TP53.
- Previous diagnosis of breast or ovarian cancer or personal history of lobular carcinoma in situ (LCIS) or breast hyperplasia (with or without atypia).
- Being a member of a focus group that assisted with the development of the intervention.
Key Trial Info
Start Date :
June 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2026
Estimated Enrollment :
874 Patients enrolled
Trial Details
Trial ID
NCT05325151
Start Date
June 13 2022
End Date
March 30 2026
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210